Our research by region
We invest in world-class blood cancer research all over the UK. Below you can find out more about some of the research going on in your region.
London and South East
Our research in London and the South East of England is revealing how blood cancer works, driving smarter and faster diagnosis, and inspiring new treatments and care. We have Trials Acceleration Programme (TAP) centres in Oxford and at King’s College, University College and Bart’s hospitals.
Institute of Cancer Research
University College London
University College London is renowned for its pioneering research and clinical expertise in delivering new and better treatments to patients with blood cancers, including leukaemia, lymphoma and myeloma in London and across the UK. We currently have £10.5 million invested across 14 projects and six programmes.
Birmingham and the Midlands are really important to us. Our Trials Acceleration Programme hub is based in Birmingham as well as centres in Birmingham, Leicester and Nottingham. Last year we made eight new awards to researchers in the region.
Lots of exciting research is going on in the North, and two of our key ‘infrastructure’ projects are based in the region. Yorkshire is home to the Haematological Malignancy Research Network, which provides the most accurate and detailed data on all types of blood cancers in the world, broken down by key demographics and biological features. The Childhood Leukaemia CellBank is based in Stockport – it’s a central UK repository for samples of bone marrow and other tissues donated by children with leukaemia, for use in specialist research projects. Last but not least we have two Trials Acceleration Programme centres in Leeds and Manchester.
Our research in Scotland is revealing how blood cancer works, driving smarter and faster diagnosis, and inspiring new treatments and care. Our innovative Trials Acceleration Programme has a centre based in Glasgow.
University of Edinburgh
Our current work in Edinburgh is focused on two important areas of blood cancer research. The first is improving treatments for patients with lymphoma and the second is cutting-edge stem cell research. We currently have £2.5 million invested across four projects and one programme.
Our research in the South West is based around the universities of Southampton, Bristol and Plymouth. Work going on at these institutions will help patients with many different types of blood cancers. We also have a Trials Acceleration Programme centre in Southampton and fund work in a special genetics laboratory in Salisbury.
Some of our most exciting research is going on in Wales, particularly around chronic lymphocytic leukaemia. We also have a Trials Acceleration Programme centre in Cardiff.
Our research in Northern Ireland is revealing how acute myeloid leukaemias and related conditions develop, so we can design new treatments and better care. There's also a Trials Acceleration Programme centre in Belfast.